4//SEC Filing
HOLMLUND JON T 4
Accession 0000899243-20-012872
CIK 0001563577other
Filed
May 11, 8:00 PM ET
Accepted
May 12, 7:00 PM ET
Size
19.6 KB
Accession
0000899243-20-012872
Insider Transaction Report
Form 4
HOLMLUND JON T
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2020-05-08$1.07/sh+5,102$5,459→ 5,102 total - Sale
Common Stock
2020-05-08$12.00/sh−5,102$61,224→ 0 total - Exercise/Conversion
Common Stock
2020-05-11$1.07/sh+185$198→ 185 total - Sale
Common Stock
2020-05-11$12.00/sh−185$2,220→ 0 total - Exercise/Conversion
Common Stock
2020-05-12$1.07/sh+671$718→ 671 total - Sale
Common Stock
2020-05-12$12.00/sh−671$8,052→ 0 total - Exercise/Conversion
Stock Option
2020-05-08−5,102→ 8,695 totalExercise: $1.07Exp: 2023-01-22→ Common Stock (5,102 underlying) - Exercise/Conversion
Stock Option
2020-05-11−185→ 8,510 totalExercise: $1.07Exp: 2023-01-22→ Common Stock (185 underlying) - Exercise/Conversion
Stock Option
2020-05-12−671→ 7,839 totalExercise: $1.07Exp: 2023-01-22→ Common Stock (671 underlying)
Footnotes (3)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 18, 2019.
- [F2]The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $12.00 to $12.05. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The option has fully vested and is currently exercisable.
Documents
Issuer
Galera Therapeutics, Inc.
CIK 0001563577
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001227367
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 7:00 PM ET
- Size
- 19.6 KB